AECC
AECC Innova
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
No deadline is on file for this call. Check AECC's own call page for the current round's status before you plan around it.
AECC Innova funds translational cancer research projects in Spain that are close to clinical or market application, spanning technology readiness levels 6 through 9. The 2026 call targets teams ready to move a cancer therapy, diagnostic, or intervention toward real-world use rather than early-stage discovery. AECC runs this call annually as part of its broader cancer research funding programme.
Details
| Funder | AECC |
| TRL | 6-9 |
| Frequency | Annual |
| Eligible countries | ES |
Eligibility & scope
AECC 2026 call funding innovative, near-market translational cancer research projects in Spain.
Who Should Apply
- •Research teams with cancer projects already validated at a proof-of-concept or later stage (TRL 6-9)
- •Institutions and researchers based in Spain
- •Projects focused on translational or applied cancer research rather than basic science
- •Teams with a clear near-term path toward clinical or commercial application
Key Dates
- •2026 call cycle, part of AECC's annual funding programme
- •Targets projects at TRL 6-9 (late-stage translational, near-market)
Tips for Applicants
- ✓Frame the proposal around a clear path to clinical or commercial deployment, since TRL 6-9 scope means reviewers expect demonstrated feasibility, not exploratory science.
- ✓Highlight any existing prototypes, pilot data, or regulatory groundwork already completed, as this call favors projects with a short runway to patients or market.
- ✓Confirm all project partners and host institutions are based in Spain before applying, since eligibility is restricted to Spanish projects.
Frequently Asked Questions
What does AECC Innova fund?
It funds near-market translational cancer research projects at technology readiness levels 6 to 9, meaning work close to clinical or commercial application.
Who is eligible for AECC Innova?
Researchers and institutions based in Spain working on translational cancer research are eligible to apply.
Is AECC Innova a recurring call?
Yes, AECC runs this call annually, with the 2026 edition open for translational cancer projects.
What TRL range does AECC Innova target?
Projects must sit within TRL 6-9, the late-stage development and near-market range rather than early discovery research.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Next steps
CancerfondenDeadline: 15 Dec 2026Clinical Innovator
Cancer Research InstituteDeadline: 1 Dec 2026$1MCaixaResearch Health Call
la Caixa FoundationDeadline: 18 Nov 2026Ramón y Cajal 2026
Agencia Estatal de Investigación (AEI)Deadline: 10 Dec 20265-year tenure-track contract + research fundsCDD Scouting Programme
KWFUp to €2M per project
Could AECC Innova be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →